Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Aethlon Medical establishes ESI as a wholly owned subsidiary

Aethlon Medical establishes ESI as a wholly owned subsidiary

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Bristol-Myers Squibb reports strong sales and earnings growth for third quarter 2009

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

Musculoskeletal patients and their advocates to participate in more than 175 Congressional visits

GeneNews announces the publication of a paper in the Journal of Clinical Gastroenterology

GeneNews announces the publication of a paper in the Journal of Clinical Gastroenterology

Schering-Plough announces 2009 third quarter financial results

Schering-Plough announces 2009 third quarter financial results

Pharmos announces results of its Phase 2b Dextofisopam trial

Pharmos announces results of its Phase 2b Dextofisopam trial

Medicare Fraud Strike Force in Houston files charges against six individuals for false and fraudulent claims

Medicare Fraud Strike Force in Houston files charges against six individuals for false and fraudulent claims

Laser Spine Institute acquires Aspen Back & Body

Laser Spine Institute acquires Aspen Back & Body

Study results of PTH1-34 oral parathyroid hormone presented

Study results of PTH1-34 oral parathyroid hormone presented

Collection of rheumatology research articles published

Collection of rheumatology research articles published

CombinatoRx announces Synavive Phase 2 extension trial results at the 2009 ACR meeting

CombinatoRx announces Synavive Phase 2 extension trial results at the 2009 ACR meeting

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Logical Therapeutics to present its clinical study results on LT-NS001

Logical Therapeutics to present its clinical study results on LT-NS001

Biogen Idec announces total revenues of $1.12 billion for third quarter 2009

Biogen Idec announces total revenues of $1.12 billion for third quarter 2009

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

Elan and Biogen Idec to present TYSABRI study data at ACG meeting

RA patients who adhere to their prescription drug regimen have better outcome: Study

RA patients who adhere to their prescription drug regimen have better outcome: Study

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials

AstraZeneca and POZEN announce the pivotal data from two POZEN clinical trials

NicOx presents data on its phase 3 naproxcinod study at the ACR meeting

NicOx presents data on its phase 3 naproxcinod study at the ACR meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.